Azenta (AZTA) Liabilities and Shareholders Equity (2010 - 2026)
Azenta's (AZTA) quarterly Liabilities and Shareholders Equity came in at $1.9 billion in Q1 2026, down 6.4% year-on-year from $2.0 billion in Q1 2025, and down 8.22% on a QoQ basis from $2.1 billion in Q4 2025.
Azenta (AZTA) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Azenta (AZTA) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $1.9 billion in Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity fell 6.4% year-over-year to $1.9 billion in Q1 2026; TTM through Mar 2026 was $8.1 billion, a 5.22% decrease from a year earlier, with the FY2025 full-year figure at $2.1 billion, changed N/A from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $1.9 billion, down from $2.1 billion in the prior quarter.
- Over the last five years, Liabilities and Shareholders Equity for AZTA reached as high as $4.2 billion in Q1 2022 and fell as low as $1.9 billion in Q1 2026.
- Historically, Liabilities and Shareholders Equity has averaged $2.7 billion across 5 years, with a median of $2.6 billion in 2024.
- Across the five-year window, Liabilities and Shareholders Equity surged 149.93% in 2022 and retreated 27.67% in 2024, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $3.3 billion in 2022, then declined by 14.22% to $2.8 billion in 2023, then slipped by 27.67% to $2.0 billion in 2024, then rose by 1.55% to $2.1 billion in 2025, then slipped by 8.22% to $1.9 billion in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $1.9 billion in Q1 2026, $2.1 billion in Q4 2025, and $2.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 31.62 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 50.83 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 39.01 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 8.78 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 14.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 6.31 Bn |
| 10 | Azenta | 1.30 Bn | 1.07 Bn | 125.74 Mn | 1.90 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.90 Bn |
| Dec 31, 2025 | 2.07 Bn |
| Sep 30, 2025 | 2.06 Bn |
| Jun 30, 2025 | 2.02 Bn |
| Mar 31, 2025 | 2.03 Bn |
| Dec 31, 2024 | 2.04 Bn |
| Sep 30, 2024 | 2.10 Bn |
| Jun 30, 2024 | 2.32 Bn |
| Mar 31, 2024 | 2.56 Bn |
| Dec 31, 2023 | 2.82 Bn |
| Sep 30, 2023 | 2.89 Bn |
| Jun 30, 2023 | 3.07 Bn |
| Mar 31, 2023 | 3.25 Bn |
| Dec 31, 2022 | 3.29 Bn |
| Sep 30, 2022 | 3.72 Bn |
| Jun 30, 2022 | 3.72 Bn |
| Mar 31, 2022 | 4.16 Bn |
| Dec 31, 2021 | 1.85 Bn |
| Sep 30, 2021 | 1.82 Bn |
| Jun 30, 2021 | 1.76 Bn |